The incidence and risk factors of pulmonary infection complications in lung cancer patients treated with immune checkpoint inhibitors
Haixia Yang, Yaxuan Han, Xiaosha Zhou, Jianying Li, Yanjun Zhao, Shanshan Zhang · 2025
Read The incidence and risk factors of pulmonary infection complications in lung cancer patients treated with immune checkpoint inhibitors by Haixia Yang, Yaxuan Han, Xiaosha Zhou, Jianying Li, Yanjun Zhao, Shanshan Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12706925.txt.
Description
Haixia Yang, Yaxuan Han, Xiaosha Zhou, Jianying Li, Yanjun Zhao, and Shanshan Zhang study lung infections in lung cancer patients treated with immune checkpoint drugs, in work from 2025. A related lung swelling from these drugs is well known, but infections after their use were less mapped. The team reviewed records at one center.
Of 107 patients, forty-four developed lung infections over a median follow-up of eight months. About half of those cases were proven by germ tests, and the rest were judged on clinical grounds. Some patients had more than one infection. The team weighed which traits raised infection risk. The results aim to guide watch and early treatment in this group.
Catalog record
| CREATOR | Haixia Yang, Yaxuan Han, Xiaosha Zhou, Jianying Li, Yanjun Zhao, Shanshan Zhang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |